Skip to main content
UniHealth

Doctor search

Diana Peta-Ga English, MD

Obstetrics/Gynecology · Ft Lauderdale

NPI 1932357241

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Holy Cross Hospital Inc · 299 clinicians in this group

Looking this up.

Hospitals listed: Holy Cross Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. English’s office at (954) 229-6000 to ask if they take your plan before you enroll.

State licence records

1 licence

  • Florida ME136881Medical Doctor · since 2018 · expires 2028-01-31
    ActiveNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

School, training and certification

2 placements

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • Gyn-Oncologycertified 2017
  • Obstetrics And Gynecologycertified 2016

Education

  • Univ. of the West Indies1999–2005

Residency and fellowship

  • Yale University School of Medicine, OTHERNew Haven, CT · 2012–2015
  • Univeristy of Miami/Jackson Memorial Hospital, OBSTETRICS AND GYNECOLOGYMiami, FL · 2008–2012

What else the board holds

Hospitals they may admit to

Where the clinician told their state board they may admit and treat patients.

  • Stanford University School of Medicine · CA

Also licensed in

States the clinician told their board they are also licensed in. Only the states we check are verified.

California

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Holy Cross HospitalFt Lauderdale, FLAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Trinity Health, which runs 105 hospitals in 16 statesPatients rate it 2 of 5 · 69% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.207, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Holy Cross Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 2 better, 8 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Holy Cross Hospital
Clostridium Difficile (C.Diff)Infections0.207BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.72 (0.76 to 2.68) · 1,237 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.14 (0.83 to 1.44)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths131.84 (82.64 to 181.05) · 86 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.7 · 48 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 204 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.9 · 251 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.1 · 474 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.4 · 626 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12.8 · 377 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths4 · 4,342 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.38) · 7,857 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.08 to 0.46) · 8,283 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.4 (1.42 to 5.37) · 1,823 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.75 (0.19 to 3.32) · 694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.6 (1.14 to 4.06) · 1,673 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths14.54 (7.77 to 21.31) · 728 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.64 (2.91 to 10.37) · 664 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.18 to 3.15) · 327 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.42 (0 to 1.02) · 6,197 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.3 · 182 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.63No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.499No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.2 · 412 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.1 · 831 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-4.3 · 269 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-11 · 561 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits6.8 · 699 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.5 · 978 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.6 (3.3 to 6.4) · 249 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.9 (7.8 to 12.5) · 249 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.2 · 183 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.4 · 74 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.7 · 334 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.5 (8.9 to 14.8) · 1,489 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 1,111 casesNo differentJan 2024 – Dec 2024

What patients said (1,092 patients answered, 26% of those asked)

Patient survey stars by topic at Holy Cross Hospital
Cleanliness2
Nurse communication2
Doctor communication2
Communication about medicines1
Discharge information2
Overall hospital rating2
Quietness2
Recommend hospital3
Share of patients giving the best answer at Holy Cross Hospital
Room was "always" clean62%
Nurses "always" communicated well70%
Doctors "always" communicated well70%
Staff "always" explained47%
Yes, staff "did" give patients this information79%
Yes, staff "did" give patients information about help after discharge79%
Doctors "always" explained things so they could understand64%
Doctors "always" listened carefully67%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)61%
Staff "always" explained new medications65%
Nurses "always" explained things so they could understand66%
Nurses "always" listened carefully66%
Nurses "always" treated them with courtesy and respect78%
"Always" quiet at night40%
"YES", patients would definitely recommend the hospital69%
Staff "always" explained possible side effects29%
Yes, staff "did" give patients information about possible symptoms79%

Original Medicare doctor bills

$21,150

Medicare paid this office $21,150 for 77 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)33$3,368$80
Long return visit (40+ min)13$1,595$106
New patient visit (60+ min)11$1,508$137

Procedures Medicare counted

Procedure volume Medicare published
Removal of the uterus1-10None

Who their Medicare patients are

77 Original Medicare patients in 2024. Average age 72 · Also on Medicaid 20% · Health risk score 1.94. Sicker patients than 9 in 10 peers; the typical obstetrics & gynecology clinician is at 0.88.

Conditions among them: High blood pressure 75% · Cancer 42% · Chronic kidney disease 32% · Coronary heart disease 29% · Depression 27% · Diabetes 22% · Atrial fibrillation 22% · Heart failure 17% · COPD 17%.

The office billed $98,196, Medicare allowed $28,813 and paid $21,150; for 153 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202477153721.94$98,196$21,150
202381222692.46$102,408$30,281
202271237702.35$95,840$26,720
202196320712.50$142,048$39,713
202077238702.91$125,340$34,012
20192146691.59$31,983$6,974
2018103220702.67$194,041$26,475
2017162534691.99$497,982$77,364
2016116437692.02$329,024$56,405
201595151722.06$157,089$14,540
2014224322711.73$305,755$29,145
2013123150721.60$122,933$12,888

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)50$12,138$106
New patient visit (60+ min)25$3,549$142

2022: 2 services

Original Medicare services billed in 2022
Long return visit (40+ min)39$9,656$105
New patient visit (60+ min)16$2,141$134

2021: 5 services

Original Medicare services billed in 2021
Long return visit (40+ min)37$11,420$115
Return visit (30+ min)29$5,271$79
New patient visit (60+ min)36$5,160$143
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,679$158
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes14$876$31

2020: 4 services

Original Medicare services billed in 2020
Long return visit (40+ min)25$4,543$87
New patient visit (60+ min)30$4,160$139
Return visit (30+ min)22$2,937$64
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes12$891$33

2018: 3 services

Original Medicare services billed in 2018
Short return visit (20+ min)33$1,707$40
Short return visit (20+ min)30$1,567$46
Short return visit11$207$17

2017: 12 services

Original Medicare services billed in 2017
Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less13$8,094$623
Return visit (30+ min)44$4,174$64
Short return visit (20+ min)46$3,048$44
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes25$2,507$34
New patient visit (45+ min)18$2,017$112
Return visit (30+ min)26$1,918$56
New patient visit (60+ min)13$1,890$145
New patient visit (45+ min)17$1,889$111
Short return visit (20+ min)29$1,815$44
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes13$1,218$87
Short return visit17$397$21
Short return visit13$287$22

2016: 9 services

Original Medicare services billed in 2016
Return visit (30+ min)32$4,187$66
Return visit (30+ min)24$3,661$65
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes25$3,042$34
New patient visit (45+ min)15$1,696$113
New patient visit (45+ min)14$1,575$112
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,505$84
New patient visit (60+ min)11$1,487$135
Short return visit (20+ min)17$1,198$43
Short return visit14$321$19

2015: 1 service

Original Medicare services billed in 2015
Return visit (30+ min)62$3,360$52

2014: 4 services

Original Medicare services billed in 2014
Long return visit (40+ min)97$7,644$72
Return visit (30+ min)94$6,886$64
Release of scar tissue at ureter13$1,689$130
Short return visit12$275$21

2013: 2 services

Original Medicare services billed in 2013
Return visit (30+ min)62$4,043$62
Long return visit (40+ min)38$3,444$88

Medicaid work

$2,327 in 2024

Medicaid paid $2,327 for 41 billed services this clinician did in 2024, up to 18 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)41$2,327
Medicaid work by year
202441118$2,327
2023960737$22,897
20229671232$19,984
202161118$4,762
201849118$1,232
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)420$18,518
OFF/OP EST MAY X REQ PHY/QHP53$4,379
TOBACCO NON-USER158$0
COLORECTAL CANCER SCREENING RESULTS DOC&REV57$0
Bmi documented outside normal parameters, no follow-up plan documented, no reason given70$0
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications150$0
Flu immunize no admin52$0

2022

Largest Medicaid services in 2022
Long return visit (40+ min)274$13,889
OFF/OP EST MAY X REQ PHY/QHP57$4,944
Short return visit17$1,113
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count15$38
TOBACCO NON-USER156$0
COLORECTAL CANCER SCREENING RESULTS DOC&REV108$0
Patient screened for tobacco use and received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user (PV, CAD)18$0
Bmi documented outside normal parameters, no follow-up plan documented, no reason given16$0
Bmi is documented within normal parameters and no follow-up plan is required30$0
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications47$0
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given121$0
Flu immunize no admin108$0

2021

Largest Medicaid services in 2021
Short return visit61$4,762

2018

Largest Medicaid services in 2018
Short return visit (20+ min)49$1,232

Drugs they prescribed that Part D paid

$295,539

Pharmacies billed $295,539 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 20% of their Part D prescriptions (58 of 298) in 2024. A higher opioid share than 9 in 10 peers; the typical obstetrics & gynecology clinician is at 0%.

267 generic and 31 brand-name prescriptions · $295,539 in drug cost · 19 antibiotic prescriptions to 11 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lynparza13$182,725$14,056
Prochlorperazine Maleate15$408$27
Oxycodone45$277$6
Ondansetron31$166$5
Ibuprofen30$113$4
See all 6 drugs
Every Part D drug this clinician prescribed
Lynparza13$182,725$14,056
Prochlorperazine Maleate15$408$27
Oxycodone45$277$6
Ondansetron31$166$5
Ibuprofen30$113$4
Gabapentin11$75$7

Year by year

Part D prescribing by year
20242989220% (58)10%$295,539
202376110839% (293)None$410,877
20225198440% (208)9%$138,388
202157511533% (187)10%$361,022
202040810527% (110)11%$176,329
2019792523% (18)None$2,371
201815845None13%$60,875
201738188None8%$83,404
201640377NoneNone$61,348
2015173656% (11)11%$20,136
201425710411% (27)14%$18,792
20131234815% (19)24%$8,418

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Lynparza23$265,158$11,529
Ondansetron Odt27$3,085$114
Oxycodone153$3,021$20
Morphine Sulfate Er66$2,066$31
Ramelteon18$1,908$106
Morphine Sulfate19$873$46
Gabapentin56$862$15
Pregabalin20$753$38
Hydromorphone23$500$22
Lactulose31$489$16
Duloxetine15$401$27
Dicyclomine11$369$34
Escitalopram31$364$12
Prochlorperazine Maleate15$278$19
Mirtazapine15$181$12
Methadone12$164$14
Lorazepam26$150$6

2022: 10 drugs

Part D drugs prescribed in 2022
Oxycodone104$2,608$25
Morphine Sulfate Er49$2,142$44
Gabapentin34$861$25
Ondansetron Odt15$855$57
Cyclobenzaprine12$564$47
Morphine Sulfate16$562$35
Mirtazapine19$555$29
Escitalopram26$355$14
Venlafaxine Hcl Er13$267$21
Methadone16$188$12

2021: 13 drugs

Part D drugs prescribed in 2021
Lynparza20$263,588$13,179
Oxycodone108$2,240$21
Morphine Sulfate Er25$1,128$45
Mirtazapine29$1,079$37
Cyclobenzaprine13$1,070$82
Ondansetron Odt15$905$60
Oxycodone-Acetaminophen19$870$46
Gabapentin54$856$16
Dicyclomine14$452$32
Escitalopram34$285$8
Ibuprofen27$224$8
Methadone14$151$11
Sertraline11$136$12

2020: 9 drugs

Part D drugs prescribed in 2020
Lynparza11$160,613$14,601
Enoxaparin12$3,597$300
Megestrol Acetate12$2,757$230
Oxycodone53$868$16
Ondansetron Odt13$294$23
Escitalopram21$226$11
Ibuprofen25$182$7
Gabapentin27$154$6
Tramadol19$60$3

2018: 3 drugs

Part D drugs prescribed in 2018
Enoxaparin15$6,531$435
Ondansetron14$255$18
Letrozole15$232$15

2017: 12 drugs

Part D drugs prescribed in 2017
Enoxaparin17$5,406$318
Megestrol Acetate11$1,031$94
Polyethylene Glycol 335015$221$15
Gabapentin16$213$13
Ondansetron16$129$8
Metformin12$91$8
Ibu14$61$4
Prochlorperazine Maleate11$60$5
Metoclopramide13$58$4
Lisinopril-Hydrochlorothiazide12$51$4
Amlodipine Besylate12$40$3
Famotidine11$26$2

2016: 10 drugs

Part D drugs prescribed in 2016
Enoxaparin14$3,866$276
Megestrol Acetate15$909$61
Glipizide-Metformin13$649$50
Atorvastatin12$204$17
Metoclopramide15$148$10
Amlodipine Besylate11$92$8
Ibuprofen18$92$5
Losartan12$74$6
Metformin16$71$4
Lisinopril-Hydrochlorothiazide13$60$5

2015: 2 drugs

Part D drugs prescribed in 2015
Estrace14$2,895$207
Prochlorperazine Maleate17$166$10

2014: 5 drugs

Part D drugs prescribed in 2014
Estrace19$3,215$169
Nystatin12$220$18
Gabapentin17$183$11
Prochlorperazine Maleate15$167$11
Levothyroxine12$148$12

2013: 1 drug

Part D drugs prescribed in 2013
Estradiol11$531$48

Money from drug and device companies

$1,326 in 2025

Industry payments by year
202558$1,088$1,326
2024813$2,740$3,028
2023410$700$1,041
202211None$27
202125$1,395$1,579
2019217$13,675$16,397

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GlaxoSmithKlineJemperli$1,104
2 payments
  • Consulting for Jemperli · 2025-10-10 · $1,088
  • Meals for Jemperli · 2025-08-06 · $16
AbbvieElahere$168
3 payments
  • Meals for Elahere · 2025-12-16 · $27
  • Meals for Elahere · 2025-06-14 · $127
  • Meals for Elahere · 2025-03-11 · $14
Myriad Genetic LaboratoriesMyrisk$21
1 payment
  • Meals for Myrisk · 2025-04-09 · $21
AstraZeneca Pharmaceuticals LPLynparza$17
1 payment
  • Meals for Lynparza · 2025-10-21 · $17
Corcept TherapeuticsKorlym$16
1 payment
  • Meals for Korlym · 2025-07-29 · $16
See all 8 published payments
Every published payment
AbbvieMeals · 2025-12-16Elahere$27
AstraZeneca Pharmaceuticals LPMeals · 2025-10-21Lynparza$17
GlaxoSmithKlineConsulting · 2025-10-10Jemperli$1,088
GlaxoSmithKlineMeals · 2025-08-06Jemperli$16
Corcept TherapeuticsMeals · 2025-07-29Korlym$16
AbbvieMeals · 2025-06-14Elahere$127
Myriad Genetic LaboratoriesMeals · 2025-04-09Myrisk$21
AbbvieMeals · 2025-03-11Elahere$14
See earlier years (2024, 2023, 2022, 2021, 2019)

2024: $3,028

Payments by company in 2024
AstraZeneca Pharmaceuticals LPNone$2,740
1 payment
  • Consulting · 2024-12-14 · $2,740
Myriad Genetic LaboratoriesPrecisetumor$75
3 payments
  • Meals for Precisetumor · 2024-11-11 · $21
  • Meals for Precisetumor · 2024-10-15 · $26
  • Meals for Precisetumor · 2024-07-02 · $28
Novartis PharmaceuticalsKisqali$54
2 payments
  • Meals for Mekinist · 2024-11-08 · $27
  • Meals for Kisqali · 2024-10-18 · $27
EisaiLenvima$50
2 payments
  • Meals for Lenvima · 2024-08-18 · $26
  • Meals for Lenvima · 2024-04-29 · $24
GlaxoSmithKlineJemperli$48
2 payments
  • Meals for Jemperli · 2024-12-11 · $29
  • Meals for Jemperli · 2024-09-03 · $19
Astellas Pharma USVeozah$27
1 payment
  • Meals for Veozah · 2024-08-20 · $27
Daiichi SankyoEnhertu$18
1 payment
  • Meals for Enhertu · 2024-09-05 · $18
AbbvieElahere$16
1 payment
  • Meals for Elahere · 2024-09-24 · $16

2023: $1,041

Payments by company in 2023
MedtronicSynchromedii$718
2 payments
  • Meals for Synchromedii · 2023-05-23 · $18
  • Consulting · 2023-01-24 · $700
EisaiLenvima$159
4 payments
  • Meals for Lenvima · 2023-11-01 · $111
  • Education for Lenvima · 2023-10-04 · $16
  • Education for Lenvima · 2023-09-26 · $8
  • Meals for Lenvima · 2023-06-26 · $24
GlaxoSmithKlineJemperli$124
2 payments
  • Meals for Jemperli · 2023-03-27 · $103
  • Meals for Jemperli · 2023-02-10 · $21
Ethicon USStratafix$40
1 payment
  • Meals for Stratafix · 2023-11-16 · $40

2022: $27

Payments by company in 2022
Ethicon USDermabond Prineo$27
1 payment
  • Meals for Dermabond Prineo · 2022-12-18 · $27

2021: $1,579

Payments by company in 2021
MedtronicNone$1,395
2 payments
  • Consulting · 2021-12-09 · $595
  • Consulting · 2021-07-21 · $800
GlaxoSmithKlineZejula$184
3 payments
  • Meals for Zejula · 2021-08-06 · $17
  • Meals for Zejula · 2021-06-01 · $21
  • Meals for Zejula · 2021-05-04 · $145

2019: $16,397

Payments by company in 2019
AstraZeneca Pharmaceuticals LPLynparza$16,272
16 payments
  • Paid to speak or teach for Lynparza · 2019-07-09 · $1,950
  • Meals for Lynparza · 2019-07-05 · $25
  • Travel for Lynparza · 2019-07-05 · $741
  • Paid to speak or teach for Lynparza · 2019-05-30 · $775
  • Paid to speak or teach for Lynparza · 2019-05-30 · $3,100
  • Paid to speak or teach for Lynparza · 2019-05-02 · $3,100
  • Paid to speak or teach for Lynparza · 2019-04-18 · $1,150
  • Travel for Lynparza · 2019-03-27 · $838
  • Meals for Lynparza · 2019-03-27 · $125
  • Meals for Lynparza · 2019-03-21 · $26
  • Travel for Lynparza · 2019-03-21 · $286
  • Meals for Lynparza · 2019-03-21 · $22
  • Meals for Lynparza · 2019-03-21 · $126
  • Travel for Lynparza · 2019-03-21 · $409
  • Paid to speak or teach for Lynparza · 2019-01-14 · $1,250
  • Paid to speak or teach for Lynparza · 2019-01-10 · $2,350
Clovis OncologyRubraca$125
1 payment
  • Meals for Rubraca · 2019-07-10 · $125

Professional record

NPI
1932357241
Licence
FL ME136881Florida ME136881: Active
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
FL 103143200
Taxonomy
Federal specialty code 207V00000X (207V00000X)
Mailing address
Po Box 917770, Orlando, FL, 32891
NPI first listed
2008-08-29
NPI last updated
2022-01-13
NPI record certified
2022-01-13

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305

This office lists an electronic records connection.